Please login to the form below
PAD
This page shows the latest PAD news and features for those working in and with pharma, biotech and healthcare.
NHS achieves new record for cancer checks for patients
The NHS is currently developing a Cancer Vaccine Launch Pad to identify thousands of patients suitable for cancer vaccine trials, with the first patient recruitment to occur this autumn.
Latest news
-
Pandemic Antiviral Discovery initiative created by the Novo Nordisk Foundation, Open Philanthropy and the Gates Foundation
The PAD initiative has been set up to aid the discovery and early development of antiviral medicines for future pandemics. ... The funding partners involved in PAD will use various models, including direct grants and requests for proposals (RFPs), within
-
Citryll snares €15m backing for its autoimmune disease NETs
Other companies including Bristol-Myers Squibb (via its $600m acquisition of Padlock Therapeutics in 2016) are working on small-molecule PAD inhibitors for autoimmune disease. ... Citryll thinks however that its approach – which works downstream of PAD
-
AZ says Brilinta hits the mark in diabetic heart disease
It’s not all been positive for Brilinta in the last couple of years, with the drug failing to show efficacy in back-to-back stroke and peripheral artery disease (PAD)
-
J&J earnings top expectations, but feels the squeeze in US
This includes cardiovascular blockbuster Xarelto, which saw a 14.4% decline, despite the FDA approving a new 2.5mg dose for those with chronic coronary or peripheral arterial disease (CAD/PAD).
-
Astellas makes another gene therapy play with Juventas deal
and late-stage peripheral artery disease (PAD).
More from news
Approximately 1 fully matching, plus 47 partially matching documents found.
Latest Intelligence
-
Product launches: making the most of your one shot
Building a solid launch pad: launch excellence frameworks. Just as rocket launches need a dependable launch pad, so pharma company launches fly better from a solid foundation, in the shape of
-
Launch engagement
programmes that brought therapies to the launch pad.
-
Changing healthcare communications
Admittedly, it’s not all roses around the layout pad and creative unicorns skipping through the office.
-
Mylan sees the UK paving the way for an insulin game changer
Mylan, the global healthcare company, has chosen the UK for the launch pad of its much-anticipated biosimilar version of the Sanofi blockbuster Lantus (insulin glargine), which it hopes will become
-
Deal Watch March 2016
Padlock's technology targets autoimmune disorders with protein/peptidyl arginine deiminase (PAD) inhibitors and offers the potential to prevent disease development in patients with early stage disease. ... Protein/peptidyl arginine deiminase (PAD)
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Why people join a clinical trial
If a lily pad patch doubles in size every day, and it covers the entire lake in 48 days, how long will it take the lily pad patch to cover half ... This is what we showed you with the lily pad question - the likelihood is that you had the initial answer
-
The impossible launch
The immense rocket hauls itself off the launch pad as the sky rumbles and we are jolted by the shockwave.
-
The Exhibition Hall: Past, Present and Future
There were small hand-held digital video cameras, laser pointers, bags, pens, Post-it note pads — you name it, we were probably giving it away.
-
IGNIFI
copy-cleared for a successful launch, including the DSA, leave piece, banner stand, box stands, deployment book, RMP materials mailer, Patient pad, Dear Dr letter, SPC cover, training slides, SPC validation,
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
- CDC awards over $23m to Johns Hopkins Center for Health Security project
- Looking to start activity on a currently unpromoted pharmaceutical brand?
- Considering a portfolio review?
No results were found
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
